HuGE Literature Finder
Records 1 - 5
| Significance of thyroid transcription factor 1 and Napsin A for prompting the status of EGFR mutations in lung adenocarcinoma patients.
Journal of thoracic disease 2022 12 14 (11): 4395-4404.
Ren Xiaolu, Wen Xiaolian, Ren Yue-Jun, Liu Xiang, Wang Jian, Hao Mingyan, Ma Qiang, Ren Jiwei, Jin Baoli, Qiao Xiaoyuan, Li Bo, Wu Jing, Li Xiaomin, Liu Zhiho
| Risk factors for brain metastases in patients with non-small cell lung cancer: a meta-analysis of 43 studies.
Annals of palliative medicine 2021 4 10 (4): 3657-3672.
Chen Shanshan, Hua Xin, Jia Jinfang, Wu Ying, Wei Shuzhen, Xu Lu, Han Shuhua, Zhang Hongming, Zhu Xiao
| Fibrinogen is associated with EGFR mutation status and lymphatic metastasis in non-small cell lung cancer.
Oncology letters 2019 Jan 17 (1): 739-746.
Guan Jian, Xiao Nan, Qiu Chun, Li Qin, Chen Min, Zhang Yao, Dai Yong, Li Lu, Zhang Yue, Yang Mi, Chen Long, Liu Lai
| Correlation between EML4-ALK, EGFR and clinicopathological features based on IASLC/ATS/ERS classification of lung adenocarcinoma.
Medicine 2018 Jun 97 (26): e11116.
Wang Hongyan, Zhang Wen, Wang Kai, Li Xiaofe
| Nonsmall cell lung cancer with rare exon 7 p.A289V mutation in the EGFR gene responds to Icotinib treatment: A case report.
Medicine 2018 12 97 (51): e13809.
Dai Limeng, Su Xuejiao, Lu Lin, Lv Dongl
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: